These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19326634)

  • 1. New oral anticoagulants: a brief review.
    Mazza JJ; Yale SH
    WMJ; 2009 Feb; 108(1):35-9. PubMed ID: 19326634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
    Merli G; Spyropoulos AC; Caprini JA
    Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants.
    Khoo CW; Tay KH; Shantsila E; Lip GY
    Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anticoagulants.
    Bauer KA
    Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
    Zikria JC; Ansell J
    Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.
    Ahrens I; Peter K; Lip GY; Bode C
    Discov Med; 2012 Jun; 13(73):445-50. PubMed ID: 22742650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban: a novel, oral, direct factor Xa inhibitor.
    Abrams PJ; Emerson CR
    Pharmacotherapy; 2009 Feb; 29(2):167-81. PubMed ID: 19170587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to warfarin--the next generation of anticoagulants.
    Kanagasabapathy P; Chowdary P; Gatt A
    Cardiovasc Ther; 2011 Dec; 29(6):e80-8. PubMed ID: 20626755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants. Part II: direct thrombin inhibitors.
    Mehta RS
    Expert Rev Hematol; 2010 Jun; 3(3):351-61. PubMed ID: 21082985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant drugs: what is new?
    Kei A; Florentin M; Elisaf M; Liberopoulos E
    Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
    Steffel J; Lüscher TF
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rivaroxaban: mode of action].
    Drouet L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for new anticoagulants: from clinical development to clinical practice.
    Apostolakis S; Lip GY; Lane DA; Shantsila E
    Cardiovasc Ther; 2011 Dec; 29(6):e12-22. PubMed ID: 20553291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Xa or thrombin: is thrombin a better target?
    Weitz JI
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():65-7. PubMed ID: 17635711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor Xa or thrombin: is factor Xa a better target?
    Ansell J
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():60-4. PubMed ID: 17635710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?
    Beyer-Westendorf J; Büller H
    J Thromb Haemost; 2011 Nov; 9(11):2153-8. PubMed ID: 21920015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implications of new oral anticoagulants: will the potential advantages be achieved?
    Phillips KW; Ansell J
    Thromb Haemost; 2010 Jan; 103(1):34-9. PubMed ID: 20062925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.